RecallDepth
Class II Terminated

Buprenorphine HCl, Injection, 0.3mg/mL, For Intramuscular or Intravenous Use, Rx Only, 1mL Single Dose Vial, (supplied in packages of 5 vials) Distributed by Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC: 42023-179-05

This recall has been terminated (originally issued November 15, 2023).

Company
Par Sterile Products Llc
Recall Initiated
November 9, 2021
Posted
November 15, 2023
Recall Number
D-0087-2024
Voluntary / Mandated
Voluntary: Firm initiated
Firm Location
Rochester, MI, United States
Official Source
View on FDA website ↗

Reason for Recall

Crystallization: presence of white, crystalline product agglomeration observed in 2 vials during annual inspection of retain samples.

Distribution

Nationwide USA

Lot / Code Info

Lot No: 343716, Exp. Date: 11/2021; Lot No: 350565, Exp. Date: 07/2022; Lot No: 26921, Exp. Date: 07/2022; Lot No: 36227, Exp. Date: 02/2023

More recalls by Par Sterile Products Llc

View all recalls by this company →

Other recent Class II Drug recalls